AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.2540
-0.0044 (-1.70%)
At close: Aug 24, 2026, 4:00 PM EDT
0.2540
0.00 (0.00%)
After-hours: Aug 24, 2026, 6:30 PM EDT
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $7.73 million as of August 24, 2026. Its market cap has increased by 3.60% in one year.
Market Cap
7.73M
Enterprise Value
1.69M
1-Year Change
3.60%
Ranking
Category
Stock Price
$0.25
ChartMarket Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $7.73M, a decrease of -81.07%. That is a compound annual growth rate of -5.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 7.73M | 139.83% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 8.52M |
| Xenetic Biosciences | 8.41M |
| Traws Pharma | 8.07M |
| Aprea Therapeutics | 8.06M |
| Azitra | 8.05M |
| Immuron | 7.96M |
| Ernexa Therapeutics | 7.93M |
| Acurx Pharmaceuticals | 7.75M |